Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant What is This Site Help Center Crisis
Powered By

Top 4 search results for "Portrazza" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
NSCLC Targeted Therapy: 8 Facts
... Targeted Therapies Approved for Use in NSCLC Class of Targeted Therapy Targeted Therapy Drugs KRAS inhibitors Adagrasib (Krazati) Sotorasib (Lumakras) EGFR inhibitors Afatinib (Gilotrif) Amivantamab (Rybrevant) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Lazertinib (Lazcluze) Necitumumab (Portrazza) Osimertinib (Tagresso) ...
NSCLC Targeted Therapy: 8 Facts
... Targeted Therapies Approved for Use in NSCLC Class of Targeted Therapy Targeted Therapy Drugs KRAS inhibitors Adagrasib (Krazati) Sotorasib (Lumakras) EGFR inhibitors Afatinib (Gilotrif) Amivantamab (Rybrevant) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Lazertinib (Lazcluze) Necitumumab (Portrazza) Osimertinib (Tagresso) ...
Biomarkers for Lung Cancer: 12 Things To Know
... These mutations help cancer cells grow and divide.Several FDA-approved treatments are available for NSCLC tumors with EGFR mutations, including: Afatinib (Gilotrif) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Necitumumab (Portrazza) Osimertinib (Tagrisso) Ramucirumab (Cyramza) Sunvozertinib (Zegfrovy) Some EGFR Treatments Depend on ...
Biomarkers for Lung Cancer: 12 Things To Know
... These mutations help cancer cells grow and divide.Several FDA-approved treatments are available for NSCLC tumors with EGFR mutations, including: Afatinib (Gilotrif) Dacomitinib (Vizimpro) Erlotinib (Tarceva) Gefitinib (Iressa) Necitumumab (Portrazza) Osimertinib (Tagrisso) Ramucirumab (Cyramza) Sunvozertinib (Zegfrovy) Some EGFR Treatments Depend on ...
How Does Targeted Therapy for Lung Cancer Work?
... Necitumumab (Portrazza) is given to people with EGFR mutations and advanced squamous cell NSCLC, a specific type.In 2024, the U.S. ...
How Does Targeted Therapy for Lung Cancer Work?
... Necitumumab (Portrazza) is given to people with EGFR mutations and advanced squamous cell NSCLC, a specific type.In 2024, the U.S. ...
Lung Cancer Treatment Options
... Small molecular inhibitors have been developed to target EGFR mutations, such as: Afatinib (Gilotrif) Amivantamab-vmjw (Rybrevant) Dacomitinib (Vizimpro) Erlotinib Gefitinib Lazertinib (Lazcluze) Necitumumab (Portrazza) Sunvozertinib (Zegfrovy) These small molecular inhibitors can shrink tumors for an extended period. ...
Lung Cancer Treatment Options
... Small molecular inhibitors have been developed to target EGFR mutations, such as: Afatinib (Gilotrif) Amivantamab-vmjw (Rybrevant) Dacomitinib (Vizimpro) Erlotinib Gefitinib Lazertinib (Lazcluze) Necitumumab (Portrazza) Sunvozertinib (Zegfrovy) These small molecular inhibitors can shrink tumors for an extended period. ...